| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of multi-metastatic melanoma with RAF1 fusion: a surprising response to anti-MEK therapy
|
Pacaud, Alizé
|
|
|
147 |
C |
p. 161-163
|
artikel
|
| 2 |
Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma
|
Di Federico, Alessandro
|
|
|
147 |
C |
p. 58-59
|
artikel
|
| 3 |
Acute renal failure under encorafenib, binimetinib and cetuximab for BRAF V600E–mutated colorectal cancer
|
Stammler, Romain
|
|
|
147 |
C |
p. 60-62
|
artikel
|
| 4 |
Adjuvant chemotherapy for pT1abN0M0 triple-negative breast cancer: a systematic review and meta-analysis of published studies
|
Petrelli, Fausto
|
|
|
147 |
C |
p. 151-153
|
artikel
|
| 5 |
A letter of response to comments on ‘A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers’
|
Dumont, Frédéric
|
|
|
147 |
C |
p. 185-186
|
artikel
|
| 6 |
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
|
Lozano, Rebeca
|
|
|
147 |
C |
p. 74-83
|
artikel
|
| 7 |
Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients
|
Gillis, Ryan D.
|
|
|
147 |
C |
p. 106-116
|
artikel
|
| 8 |
Corrigendum to ‘Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer’, [Eur J Canc 51 (2015) 482–488]
|
Ryu, Min-Hee
|
|
|
147 |
C |
p. 187
|
artikel
|
| 9 |
DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
|
Schotten, Lea M.
|
|
|
147 |
C |
p. 142-150
|
artikel
|
| 10 |
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study
|
Guarneri, Valentina
|
|
|
147 |
C |
p. 120-127
|
artikel
|
| 11 |
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110)
|
Heinrich, Kathrin
|
|
|
147 |
C |
p. 128-139
|
artikel
|
| 12 |
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
|
Kramer, Rafaela
|
|
|
147 |
C |
p. 170-181
|
artikel
|
| 13 |
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
|
Clement, Paul M.J.
|
|
|
147 |
C |
p. 1-12
|
artikel
|
| 14 |
Impact of lung metastases on overall survival in the phase 3 SELECT study of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer
|
Tahara, Makoto
|
|
|
147 |
C |
p. 51-57
|
artikel
|
| 15 |
Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis
|
Deng, Aileen
|
|
|
147 |
C |
p. 17-28
|
artikel
|
| 16 |
Neoadjuvant and adjuvant end-points in health technology assessment in oncology
|
Harbeck, Nadia
|
|
|
147 |
C |
p. 40-50
|
artikel
|
| 17 |
Patterns and prognostic significance of cutaneous immune-related adverse events in non–small cell lung cancer
|
Thompson, Leah L.
|
|
|
147 |
C |
p. 13-16
|
artikel
|
| 18 |
Perioperative chemotherapy and regional hyperthermia for high-risk adult-type soft tissue sarcomas
|
Lindner, Lars H.
|
|
|
147 |
C |
p. 164-169
|
artikel
|
| 19 |
Prevention of healthcare-associated respiratory-viral infections amongst oncology inpatients: Infection prevention outcomes during coronavirus disease-2019 pandemic
|
Wee, Liang En
|
|
|
147 |
C |
p. 117-119
|
artikel
|
| 20 |
Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study
|
Espi, M.
|
|
|
147 |
C |
p. 29-39
|
artikel
|
| 21 |
RE: Phase I dose escalation study of oxaliplatin delivered via a laparoscopic approach using pressurized intraperitoneal aerosol chemotherapy (PIPAC) for advanced peritoneal metastases of gastrointestinal tract cancers
|
Rovers, Koen P.
|
|
|
147 |
C |
p. 182-184
|
artikel
|
| 22 |
Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma
|
Fukumoto, Takeshi
|
|
|
147 |
C |
p. 140-141
|
artikel
|
| 23 |
Telomerase reverse transcriptase promoter mutation– and O6-methylguanine DNA methyltransferase promoter methylation–mediated sensitivity to temozolomide in isocitrate dehydrogenase–wild-type glioblastoma: is there a link?
|
Gramatzki, Dorothee
|
|
|
147 |
C |
p. 84-94
|
artikel
|
| 24 |
The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism
|
Wu, Sifan
|
|
|
147 |
C |
p. 63-73
|
artikel
|
| 25 |
Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer
|
Jiang, Meng
|
|
|
147 |
C |
p. 95-105
|
artikel
|
| 26 |
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
|
Giesen, Nicola
|
|
|
147 |
C |
p. 154-160
|
artikel
|
Tijdschrift beschrijving